4.5 Article

Subclinical signs in LRRK2 mutation carriers

期刊

PARKINSONISM & RELATED DISORDERS
卷 17, 期 7, 页码 528-532

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2011.04.014

关键词

Parkinson's disease; G2019S; N1437H; Premotor; Hyposmia

资金

  1. Research Council of Norway [NevroNor 1031400]
  2. Reberg's Legacy

向作者/读者索取更多资源

Background: Several non-motor features have been reported to precede the motor signs of Parkinson's disease (PD) by several years. However, the time of onset of non-motor and motor symptoms is still debated. Healthy individuals carrying a PD-related mutation are candidates for studying the earliest disease signs. Objectives: To describe clinically healthy family members of PD patients carrying a LRRK2 mutation (LRRK2-PD). Methods:A total of 47 family members of LRRK2-PD patients were included in the present study and were screened for the p.G2019S and p.N1437H substitutions in the LRRK2 gene. A standardized case report form was filled out in each case, including general medical evaluation, neurological examination with UPDRS, an olfaction test, mood, sleep and cognitive questionnaires. Results: Thirty-two study participants were positive, and 15 were negative for a LRRK2 mutation. Higher UPDRS motor scores, more frequent reports of urinary problems, and fewer hours of sleep were found in mutation carriers compared to non-carriers. The mutation carriers with UPDRS >= 8 were all aged over 50 years, had shorter overall sleeping hours, more frequent urinary and constipation problems, higher mood scores and body mass index. Deterioration of olfaction was not detected in either group. Conclusion: Healthy LRRK2 mutation carriers presented subclinical parkinsonian motor and non-motor signs in the apparent absence of olfactory loss. Longitudinal studies will determine whether these changes precede alterations detectable by neuroimaging. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据